Browsing: Sciences

Vancouver, British Columbia–(Newsfile Corp. – September 23, 2026) – Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (“Restart Life” or the “Company”) is pleased to announce the commercial online launch of its new HC Protein+ product line through Holy Crap Foods Inc. (“Holy Crap”) direct-to-consumer e-commerce platform at www.holycrap.com.

Frazier Life Sciences has raised more than $1.1 billion in new commitments for its Public Fund through an oversubscribed fundraising, bringing total committed capital for the strategy to approximately $2.8 billion.

Life sciences and healthcare companies – from pharmaceutical manufacturers and medical device makers to hospitals, care providers and digital health platforms – face a rapidly evolving cyber regulatory landscape across the EU and UK.

This is a paid press release. Contact the press release distributor directly with any enquiries.

The six-nominee board challenge remains pending; a September 24 vote could change Anavex’s board, but no governance change is disclosed yet.

Aug. 18, 2026 /PRNewswire/ — J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the appointment of Bruce N. Rogers, Ph.D., as Venture Partner. Dr. Rogers will leverage his extensive background in medicinal chemistry, translational science, neuroscience, and immunology to develop and scale…

Manitoba’s largest hospital is still working to recover from a cyberattack a week after first discovering it.

Health Sciences Centre Winnipeg is investigating a ransomware incident affecting certain facility maintenance systems, including HVAC and door access.